Welcome to RLPSecurties

Stock Quotes	Board Of Directors	Income Statement	Directors Report	Change Name	Quarterly Results
High/Low	Share Holding	Balance Sheet	Auditors Report	Book Closure	Half Yearly Results
Company Profile	MF Holding	Cash Flow	Notes to Accounts	Dividend Details	Technical Chart
Locations	Investor Returns	Ratios	Banker's/Auditor's	ADR/GDR Prices	Peer Comparision

Marksans Pharma Ltd.	LIVE QUOTES

NSE: MARKSANSEQ BSE: 524404ISIN: INE750C01026INDUSTRY: Pharmaceuticals

BSE

Rs 254.45

Open: 220.70

Today's Range 218.10

258.85

NSE
Rs 254.79
+34.53 (+ 13.55 %)

+34.20 (+ 13.44 %)

Prev Close: 220.25

52 Week Range 156.00

270.60

Registered Address

Registered Office : 11th Floor, Grandeur, Veera Desai Extension Road, Oshiwara, Andheri (West),

Mumbai, Maharashtra - 400053

Tel: 022-40012000

Fax: 022-40012011

Email : companysecretary@marksanspharma.com

Website : http://www.marksanspharma.com

Key Officials

Name	Designation
Mr. Harshavardhan Panigrahi	Co. Secretary & Compl. Officer
Mr. Jitendra Sharma	Group Chief Financial Officer
Mr. Anjani Kumar	Chief Operating Officer - US Operations

Listings

BSE , BSE , NSE ,

StandaloneConsolidated

Quarterly Trends - Standalone

Rs. in Crs.

Financial Year	Mar 26	Dec 25	Sep 25
Sales	361.57	339.73	320.44
Other Income	27.48	15.86	58.19
Total Expenses	242.32	248.26	227.38
Depreciation	8.76	8.83	8.46
Taxation	32.44	21.20	21.69
Net Profit / Loss	91.92	60.91	99.81
Equity Capital	45.32	45.32	45.32

Half Yearly Balance Sheet - Standalone

Rs. in Crs.

YearEnding	Sep 25	Mar 25
Face Value	1	1
Equity Share Capital	45.32	45.32
Reserves and Surplus	1449.75	1338.17
Total Non-Current Liabilities	28.49	26.18
Total Current Liabilities	293.29	345.64
Total Capital And Liabilities	1816.85	1755.30
Total Non-Current Assets	687.86	673.08
Total Current Assets	1128.98	1082.22
Total Assets	1816.85	1755.30

Quarterly Trends - Consolidated

Rs. in Crs.

Financial Year	Mar 26	Dec 25	Sep 25
Sales	856.11	754.43	720.41
Other Income	35.17	20.14	21.57
Total Expenses	510.88	566.69	469.77
Depreciation	24.29	24.33	26.92
Taxation	50.97	36.93	34.20
Net Profit / Loss	149.03	113.69	99.14
Equity Capital	45.32	45.32	45.32

Half Yearly Balance Sheet - Consolidated

Rs. in Crs.

YearEnding	Sep 25	Mar 25
Face Value	1	1
Equity Share Capital	45.32	45.32
Reserves and Surplus	2642.71	2421.60
Minority Interest	25.57	22.47
Total Non-Current Liabilities	273.82	272.91
Total Current Liabilities	454.64	477.34
Total Capital And Liabilities	3442.04	3239.63
Total Non-Current Assets	1087.81	1035.51
Total Current Assets	2354.24	2204.12
Total Assets	3442.04	3239.63

Corporate News

Marksans Pharma - ESOP/ESOS/ESPS

Marksans Pharma - Announcement under Regulation 30 (LODR)-Al...

Marksans Pharma - Analysts/Institutional Investor Meet/Con. ...

Marksans Pharma - Announcement under Regulation 30 (LODR)-An...

Marksans Pharma - Disclosure under SEBI Takeover Regulations

Registrar Details

Bigshare Services Pvt. Ltd.

S6-2, 6th Floor, Pinnacle Business Park, Next to Ahura Centre, Ma

Mumbai,400093,Maharashtra

Tel : 022-62638200

Fax : 62638261

BSENSE

Market Performance

Exchange	BSE	NSE
Last Traded Price (Rs.)	254.45	254.79
Last Traded Date	26/05/2026	26/05/2026
Last Traded Time	-	-
Change (%)	15.53%	15.68%
Day's Open (Rs.)	220.70	221.40
Previous Close (Rs.)	220.25	220.26
Day's High (Rs.)	258.85	258.80
Day's Low (Rs.)	218.10	218.00
Total Traded Qty	1407729	38057110
Value (Rs. In Lacs)	3482.68	94266.68
Bid Price (Rs.)	0.00	0.00
Bid Quantity
Offer Price (Rs.)	0.00	0.00
Offer Quantity
Exchange Code	524404	MARKSANSEQ
Exchange Group	A	OtherEQ

Board Meetings

Date	Purpose
26/05/2026	Audited Results & Final Dividend
05/02/2026	Quarterly Results
13/11/2025	Quarterly Results

Share Holding Pattern as on 31/03/2026

Major Holder	No. of Shares	Percentage (%)
Promoters	198,822,009	43.87
Institutional Investors	105,761,468	23.34
Other Investors	20,186,487	4.45
General Public	128,393,782	28.33

Market

Derivatives

Mutual Fund

IPO

Quick Links

Marksans Pharma Ltd.

LIVE QUOTES